| 

When Ravikumar decided to turn entrepreneur, he took a major challenge, like challenges he had taken as researcher at AstraZeneca. He wanted to develop India’s first HIV ELISA Kit and proved the skeptics wrong million times by developing it in record time and selling them in millions with venture funding by SIDBI.
The firm is working on future generation products like DNA Micro-Chips, which will revolutionize diagnostics by allowing simultaneous investigation for multiple infections instead of sequentially looking for one infection after the other, dramatically lowering the cost of the diagnostic protocol.
XCyto-Screen Meningitis, XCyto-Screen Encephalitis, XCyto-Screen HPV three main diagnostics based on Nucleic Acid Amplification technology and DNA Macro-Chip that XCyton had developed in collaboration with Shankaranetralya, Chennai; L. V. Prasad Eye Institute, Hyderabad; Center for Cellular & Molecular Biology; Hyderabad & AIIMS. New Delhi with funding from NMITLI of CSIR.
|